Navigation Links
Market Publishers Ltd and GenericsWeb Sign Partnership Agreement

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd and GenericsWeb Pty Ltd signed partnership agreement for quality market research promotion on Internet. is now authorized to distribute and sell GenericsWeb research reports.

Mrs. Alla Martin, Head of Partner Relations Department, mentioned in her comments on the agreement: "GenericsWeb is a highly professional company whose title speaks for itself – the company focuses on the pipeline products, new drugs developments, and extended patent information. We are sure that our clients will develop much interest in the products offered by GenericsWeb, among which there are regularly updated news and articles, business intelligence, industry links, product development services and e-newsletters."

In-demand market reports by GenericsWeb:

  • Repaglinide - Comprehensive Patent Search
  • Ribavirin - Comprehensive Patent Search
  • Riluzole - Comprehensive Patent Search
  • Rimonabant - Comprehensive Patent Search
  • Risedronic Acid - Comprehensive Patent Search
  • Risperidone - Comprehensive Patent Search
  • Ritonavir - Comprehensive Patent Search
  • Rituximab - Comprehensive Patent Search
  • Rivaroxaban - Comprehensive Patent Search
  • Rivastigmine - Comprehensive Patent Search

  • Each of the above mentioned reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

    Each Patent Search features:

  • Comprehensive patent searching, covering the world's key territories;
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques;
  • Patent identification, categorisation and interpretation;
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims;
  • Manual filtration of patents not relevant to generic development;
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation;
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers.

  • More details on GenericsWeb and their reports can be found at The Market Publishers, Ltd.Mrs. Alla MartinTel: +44 208 144 6009Fax: +44 207 900

    SOURCE The Market Publishers Ltd
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
    2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
    3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
    5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
    6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
    7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
    8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
    9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
    10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
    11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
    Post Your Comments:
    (Date:11/26/2015)... --> --> Juntendo University Hospital ... weighting of MRI for patients with Multiple Sclerosis (MS) ... with SyntheticMR in order to use SyMRI in clinical research ... generate multiple contrast images from a single scan and adjust ... it possible to both fine tune images and recreate additional ...
    (Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the French Drugs ...
    (Date:11/26/2015)... 26, 2015 Research and Markets ( ... Wound Care Market by Type (Dressings, Therapy Devices, Active ... Facility, Out-Patient Facility), and Geography - Global Forecast to ... --> --> The purpose of ... forecast of the global advanced wound care market. It ...
    Breaking Medicine Technology:
    (Date:11/25/2015)... ... 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever ... with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the ... the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is ...
    (Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
    (Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health ... launches new Wimbledon Athletics Facebook page to educate the public, parents ... cardiac abnormalities. About 2,000 people under the age of 25 die from sudden ...
    (Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
    (Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a ... “I thought there had to be a convenient and comfortable way to protect them ... enables disabled individuals to safely travel during cold or inclement weather. In doing so, ...
    Breaking Medicine News(10 mins):